Armstrong Advisory Group’s Bristol-Myers Squibb BMY Stock Holding History

Armstrong Advisory Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$231K	Sell	4,009 -601	-13%	-$34.5K	0.01%	230
2026 Q1	$280K	Buy	4,610 +8	+0.2%	+$466	0.02%	199
2025 Q4	$248K	Sell	4,602 -589	-11%	-$28.3K	0.02%	201
2025 Q3	$234K	Buy	5,191 +10	+0.2%	+$467	0.02%	198
2025 Q2	$240K	Sell	5,181 -967	-16%	-$47.5K	0.02%	182
2025 Q1	$348K	Hold	6,148	–	–	0.03%	138
2024 Q4	$348K	Buy	6,148 +218	+4%	+$12.2K	0.03%	138
2024 Q3	$307K	Sell	5,930 -1,996	-25%	-$93.6K	0.03%	145
2024 Q2	$329K	Sell	7,926 -338	-4%	-$15.1K	0.03%	134
2024 Q1	$424K	Hold	8,264	–	–	0.04%	112
2023 Q4	$424K	Sell	8,264 -427	-5%	-$22.4K	0.04%	112
2023 Q3	$504K	Buy	8,691 +415	+5%	+$25.4K	0.06%	86
2023 Q2	$529K	Sell	8,276 -36	-0.4%	-$2.41K	0.06%	86
2023 Q1	$576K	Buy	8,312 +2	+0%	+$141	0.07%	79
2022 Q4	$598K	Buy	+8,310	New	+$627K	0.08%	81

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Armstrong Advisory Group's BMY Position: Q2 2026 in Review

Armstrong Advisory Group reduced its Bristol-Myers Squibb (BMY) stake by 13% in Q2 2026, selling an estimated $34.5K and leaving 4,009 shares worth $231K. The position accounts for 0.01% of the portfolio, ranked #230.

Armstrong Advisory Group first reported a position in BMY in Q4 2022 and has held it in 15 quarters since. The position peaked at $598K in Q4 2022. 832 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Armstrong Advisory Group held 4,009 shares of Bristol-Myers Squibb worth $231K as of Q2 2026.
Armstrong Advisory Group sold 601 Bristol-Myers Squibb shares in Q2 2026, an estimated $34.5K.
Bristol-Myers Squibb made up 0.01% of Armstrong Advisory Group's portfolio in Q2 2026, its #230 holding.
Armstrong Advisory Group first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 15 quarters since.
Armstrong Advisory Group's Bristol-Myers Squibb position peaked at $598K in Q4 2022.
832 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Armstrong Advisory Group's 13F filing for Q2 2026, filed 13 Jul 2026.